Clinical benefit of HCV core antigen assay in patients receiving interferon and ribavirin combination therapy

Makiko Higashimoto, Masahiko Takahashi, Ritsuko Jokyu, Hidetsugu Saito

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Clinical benefit of HCV core antigen assay in patients receiving interferon and ribavirin combination therapy'. Together they form a unique fingerprint.

Medicine & Life Sciences